Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 950-2003 | Other Identifier | Other | |
| 2025P011265 | Other Identifier | Emory IRB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In the present study, investigators intend to establish a large database of cardiovascular patients. More specifically, investigators will create a database of approximately 12,000 cardiac catheterization and heart failure patients from Emory University Hospital, the Emory Clinic, Emory University Hospital Midtown, Grady Memorial Hospital, Atlanta VA Medical Center, Organized/Planned Community Events in the Atlanta Metropolitan area, held at places of Worship, local Community Centers, shopping Malls, doctor's Offices and Health Clinics and any other miscellaneous locations, e.g. Parks, Leisure centers, Conference centers.
Once the data has been collected, investigators will run a variety of statistical analyses to which will help us to learn more about the factors that cause various cardiovascular diseases such as coronary heart disease, angina, heart failure, hypertension, and stroke. The statistical analyses will also help us to understand how these diseases can be treated more effectively.
By collecting a large amount of data on a large number of cardiovascular patients, investigators will be able to analyze, with a great deal of precision, those factors that influence the onset, course, and treatment of cardiovascular disease. The results of these precise analyses can then be used to help optimize clinical efforts to prevent and treat cardiovascular disease.
Over the last several decades, scientists have made great progress in their understanding of cardiovascular disease. Nevertheless, much remains to be learned about the causes, course, and treatment of cardiovascular disease. In order to learn more about this topic, it is important to establish large databases of cardiovascular patients. These databases allows scientists to investigate, in a rigorous and precise manner, those factors that influence cardiovascular disease.
In the present study, investigators intend to establish a large database of cardiovascular patients. More specifically, investigators will create a database of approximately 12,000 cardiac catheterization and heart failure patients from Emory University Hospital, the Emory Clinic, Emory University Hospital Midtown, Grady Memorial Hospital, Atlanta VA Medical Center, Organized/Planned Community Events in the Atlanta Metropolitan area, held at places of Worship, local Community Centers, shopping Malls, doctor's Offices and Health Clinics and any other miscellaneous locations, e.g. Parks, Leisure centers, Conference centers.
Investigators will collect a large amount of data on these patients. Data to be collected will include information on:
Medical record data, including imaging Patient questionnaire data DNA and other biochemical data obtained and/or generated from patient blood samples or cheek (buccal) swabs Non-invasive measurements of blood pressure, heart rate and studies relating to assessment of the health of arteries
The data noted above will be collected by:
administering questionnaires/interviews to the patients accessing the medical records of the patients collecting blood samples from patients which will be analyzed by laboratories for their biochemical content.
Once the data has been collected, investigators will run a variety of statistical analyses to which will help us to learn more about the factors that cause various cardiovascular diseases such as coronary heart disease, angina, heart failure, hypertension, and stroke. The statistical analyses will also help investigators to understand how these diseases can be treated more effectively.
How the Research Will Advance Scientific Knowledge/Human Health:
By collecting a large amount of data on a large number of cardiovascular patients, investigators will be able to analyze, with a great deal of precision, those factors that influence the onset, course, and treatment of cardiovascular disease. The results of these precise analyses can then be used to help optimize clinical efforts to prevent and treat cardiovascular disease.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| All cause death | Continuous |
| Measure | Description | Time Frame |
|---|---|---|
| Cardiovascular death | Continuous | |
| Re-hospitalization for heart failure | Continuous |
| Measure | Description | Time Frame |
|---|---|---|
| Myocardial Infarction | Continuous | |
| Stroke | Continuous |
Inclusion Criteria:
All hospital and clinic participants aged 18 years and older
Participants with and without active or presumed cardiovascular disease including but not limited to:
Any individual aged 18 and above in satisfactory physical health and able to tolerate a blood draw or buccal swab.
Exclusion Criteria:
Significant Documented Anemia (Hemoglobin <8 g/dL)
Blood transfusions within past 3 weeks
Enrollment against doctor recommendation
Participant not able to provide consent including but not limited to:
Not provided
Not provided
Not provided
General population & patients presenting to the hospital
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ayman J Tahhan, MD | Contact | 404 712 0168 | ayman.tahhan@emory.edu | |
| Salman Sher, MD | Contact | 404 412 0170 | ssher2@emory.edu |
| Name | Affiliation | Role |
|---|---|---|
| Arshed A Quyyumi, MD | Emory School Of Medicine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Emory School Of Medicine | Recruiting | Atlanta | Georgia | 30322 | United States |
Not provided
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
60 cc of blood will be obtained from the participant. Blood will be processed and stored in -80F freezers as plasma, serum, extracted DNA and whole blood.